Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
26 November 2010
IN THIS ISSUE
Bayer restructuring
Propoxyphene withdrawal
Novartis' strategy
Roche job cuts
 
Bayer restructuring: 4500 jobs to be cut
Bayer has announced a restructuring program that includes cutting 4500 jobs, including 1700 in Germany, but the company has also said it intends to create 2500 jobs in the same period, particularly in emerging markets. More...
 
Propoxyphene pulled from US market
Following new clinical data and a request from the FDA, Xanodyne Pharmaceuticals has agreed to withdraw its prescription pain products Darvon and Darvocet (propoxyphene) from the US market. More...
 
Novartis announces restructuring
Novartis has disclosed its long-term business strategy, which emphasizes diversification in what the company described as high-growth healthcare segments. More...
 
Roche to cut 6% of workforce
Roche has announced implementation plans for its Operational Excellence Program, announced in September, which include eliminating 4800 positions worldwide over the next 2 years — 6% of its current workforce. More...
 
EMA makes decisions on opioids and follow-on biologics
The EMA's Committee for Medicinal Products for Human Use has issued a summary of its latest meeting, including the agency's procedure on modified-release oral opioids and its procedures for reviewing certain biosimilars. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Women's victory at Novartis — and setback in the Senate
Safety concerns prompted FDA's rejection of Qnexa and Lorcaserin
Pharma is over the social media hump. Now what?
More blog posts

Peer reviewed research
A proposed content uniformity test for large sample sizes
Orally disintegrating tablets using starch and fructose
Dissolution testing for inhaled drugs
More articles

Upcoming events
Pharmacovigilance and Risk Management 2011 (9–12 January | USA)
Biomanufacturing Summit 2011 (24–25 January | USA)
Cool Chain Europe 2011 (24–26 January | The Netherlands)
More events

Product Profiles
Media Fill Trials

Oxoid Cold filterable Tryptone Soya Broth has been specially developed to meet the increasing regulatory demands of undertaking aseptic process validations (media fills). This highly filterable medium allows new guidelines to be met, and aseptic process simulations without the need for heating or changing filters.
Read more...

Recruitment Profile
Genetic Identification and Characterization in less than 8 Hours
The DuPont Qualicon RiboPrinter® microbial characterization system provides the speed, accuracy and resolution needed to identify bacteria and compare them at the strain level characterization, all in less than 8 hours. This automated system is available in Europe, Canada and Australia alongside Oxoid products.
Read more...

 



Survey
Do you feel there is a need for stringent regulations relating to excipients for pharmaceutical use?
Yes
No

This week we would like to know...

Did you attend more industry trade shows/conferences this year compared with recent years?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom